Antonio Cuadrado

23.9k total citations · 9 hit papers
180 papers, 17.3k citations indexed

About

Antonio Cuadrado is a scholar working on Molecular Biology, Neurology and Epidemiology. According to data from OpenAlex, Antonio Cuadrado has authored 180 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Molecular Biology, 20 papers in Neurology and 17 papers in Epidemiology. Recurrent topics in Antonio Cuadrado's work include Genomics, phytochemicals, and oxidative stress (81 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers) and Heme Oxygenase-1 and Carbon Monoxide (16 papers). Antonio Cuadrado is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (81 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers) and Heme Oxygenase-1 and Carbon Monoxide (16 papers). Antonio Cuadrado collaborates with scholars based in Spain, United States and United Kingdom. Antonio Cuadrado's co-authors include Ana I. Rojo, Nadia G. Innamorato, John D. Hayes, Marta Pajares, Gina Manda, Marta Salinas, Isabel Lastres‐Becker, Patricia Rada, Daniel Martı́n and Marı́a L. de Ceballos and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Antonio Cuadrado

172 papers receiving 17.1k citations

Hit Papers

Therapeutic targeting of t... 2004 2026 2011 2018 2019 2011 2015 2004 2012 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
    2019 1.0k citations Antonio Cuadrado, Ana I. Rojo et al. Nature Reviews Drug Discovery profile →
  2. SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
    2011 652 citations Patricia Rada, Ana I. Rojo et al. profile →
  3. Clinical Relevance of Biomarkers of Oxidative Stress
    2015 648 citations Jeroen Frijhoff, Paul G. Winyard et al. Antioxidants and Redox Signaling profile →
  4. Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol
    2004 617 citations Ana I. Rojo, Antonio Cuadrado et al. Journal of Biological Chemistry profile →
  5. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
    2012 550 citations Antonio Cuadrado, John D. Hayes et al. profile →
  6. Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
    2020 535 citations Marta Pajares, Ana I. Rojo et al. profile →
  7. Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
    2018 506 citations Antonio Cuadrado, Gina Manda et al. profile →
  8. Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
    2019 476 citations Natalia Robledinos-Antón, Raquel Fernández-Ginés et al. profile →
  9. Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis
    2012 424 citations Patricia Rada, Ana I. Rojo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Cuadrado Spain 68 11.1k 2.3k 2.0k 1.5k 1.5k 180 17.3k
Jeffrey A. Johnson United States 60 8.4k 0.8× 2.0k 0.9× 1.7k 0.8× 725 0.5× 1.3k 0.9× 175 14.4k
Vittorio Calabrese Italy 84 8.3k 0.8× 5.3k 2.4× 2.0k 1.0× 1.7k 1.1× 1.6k 1.1× 294 18.5k
Pamela Maher United States 76 9.5k 0.9× 2.8k 1.3× 1.7k 0.9× 1.9k 1.2× 2.7k 1.8× 229 16.8k
Jin Tae Hong South Korea 63 8.0k 0.7× 2.8k 1.3× 2.0k 1.0× 3.1k 2.0× 1.1k 0.7× 681 20.1k
Emanuela Esposito Italy 66 5.0k 0.5× 2.7k 1.2× 1.5k 0.8× 2.1k 1.3× 2.4k 1.6× 441 14.9k
George E. Barreto Colombia 61 4.2k 0.4× 2.8k 1.2× 2.2k 1.1× 1.1k 0.7× 1.6k 1.1× 298 11.8k
Hideaki Hara Japan 68 8.3k 0.8× 2.4k 1.1× 2.9k 1.5× 1.1k 0.7× 3.1k 2.1× 567 19.4k
Rosanna Di Paola Italy 62 5.2k 0.5× 2.2k 1.0× 1.2k 0.6× 2.3k 1.5× 890 0.6× 402 15.3k
Rajiv R. Ratan United States 68 8.7k 0.8× 2.4k 1.1× 1.9k 1.0× 599 0.4× 3.2k 2.1× 164 15.4k
Domenico Praticò United States 81 6.3k 0.6× 7.0k 3.1× 2.0k 1.0× 3.1k 2.0× 1.3k 0.9× 305 20.7k

Countries citing papers authored by Antonio Cuadrado

Since Specialization
Citations

This map shows the geographic impact of Antonio Cuadrado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Cuadrado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Cuadrado more than expected).

Fields of papers citing papers by Antonio Cuadrado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Cuadrado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Cuadrado. The network helps show where Antonio Cuadrado may publish in the future.

Co-authorship network of co-authors of Antonio Cuadrado

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Cuadrado. A scholar is included among the top collaborators of Antonio Cuadrado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Cuadrado. Antonio Cuadrado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuadrado, Antonio, et al.. (2025). Veillonella atypica bacteraemia: Case report and literature review. IDCases. 40. e02194–e02194.
2.
Jakubowska, Monika A., Vera Marisa Costa, Wojciech Krzeptowski, et al.. (2025). Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases. Redox Biology. 87. 103891–103891. 3 indexed citations
3.
Almeida, Cláudia G., et al.. (2024). Therapeutic targeting of NRF2 in Alzheimer's disease. Free Radical Biology and Medicine. 218. 3–3.
4.
Escoll, Maribel, et al.. (2024). NRF2 activation by 6-MSITC increases the generation of neuroprotective, soluble α amyloid precursor protein by inducing the metalloprotease gene ADAM17. Free Radical Biology and Medicine. 227. 94–102. 2 indexed citations
5.
Palomino‐Antolín, Alejandra, Víctor Farré‐Alins, Ana Belén López-Rodríguez, et al.. (2023). Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4. Antioxidants. 12(9). 1729–1729. 5 indexed citations
6.
Fernández-Ginés, Raquel, et al.. (2022). The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance. Free Radical Biology and Medicine. 192. 246–260. 26 indexed citations
7.
Escoll, Maribel, et al.. (2022). Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints. Antioxidants. 11(5). 946–946. 15 indexed citations
8.
Milanesi, Elena, Maria Dobre, Ana I. Rojo, et al.. (2021). Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer’s Disease. Dove Medical Press (Taylor and Francis Group). 14 indexed citations
9.
Milanesi, Elena, Gina Manda, Maria Dobre, et al.. (2021). Distinctive Under-Expression Profile of Inflammatory and Redox Genes in the Blood of Elderly Patients with Cardiovascular Disease. Journal of Inflammation Research. Volume 14. 429–442. 10 indexed citations
10.
Estrada, Martín, Concepción Pérez, Laura Lagartera, et al.. (2020). Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties. European Journal of Medicinal Chemistry. 190. 112090–112090. 17 indexed citations
11.
Escoll, Maribel, Marta Pajares, Natalia Robledinos-Antón, et al.. (2020). Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas. Redox Biology. 30. 101425–101425. 30 indexed citations
12.
Cuadrado, Antonio, Ana I. Rojo, Geoffrey Wells, et al.. (2019). Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature Reviews Drug Discovery. 18(4). 295–317. 1034 indexed citations breakdown →
13.
Rojo, Ana I., Marta Pajares, Patricia Rada, et al.. (2017). NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology. Redox Biology. 13. 444–451. 181 indexed citations
14.
Frijhoff, Jeroen, Paul G. Winyard, Neven Žarković, et al.. (2015). Clinical Relevance of Biomarkers of Oxidative Stress. Antioxidants and Redox Signaling. 23(14). 1144–1170. 648 indexed citations breakdown →
15.
Schmidt, Harald, Roland Stocker, Claudia Vollbracht, et al.. (2015). Antioxidants in Translational Medicine. Antioxidants and Redox Signaling. 23(14). 1130–1143. 193 indexed citations
16.
Casas, Ana I., Vu Thao-Vi Dao, Andreas Daiber, et al.. (2015). Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications. Antioxidants and Redox Signaling. 23(14). 1171–1185. 108 indexed citations
17.
Jaźwa, Agnieszka, Ana I. Rojo, Nadia G. Innamorato, et al.. (2011). Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism. Antioxidants and Redox Signaling. 14(12). 2347–2360. 265 indexed citations
18.
Innamorato, Nadia G., Ana I. Rojo, Ángel J. García‐Yagüe, et al.. (2008). The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation. The Journal of Immunology. 181(1). 680–689. 420 indexed citations
19.
Marinissen, María Julia, Tamara Tanos, Marta Bolós, et al.. (2006). Inhibition of Heme Oxygenase-1 Interferes with the Transforming Activity of the Kaposi Sarcoma Herpesvirusencoded G Protein-coupled Receptor. Journal of Biological Chemistry. 281(16). 11332–11346. 65 indexed citations
20.
Vara, Elena, et al.. (1995). Production of TNF alpha, IL-1, IL-6 and nitric oxide by isolated human islets.. PubMed. 27(6). 3367–71. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey A. Johnson Breakdown of academic impact, for papers by Vittorio Calabrese Breakdown of academic impact, for papers by Pamela Maher Breakdown of academic impact, for papers by Jin Tae Hong Breakdown of academic impact, for papers by Emanuela Esposito Breakdown of academic impact, for papers by George E. Barreto Breakdown of academic impact, for papers by Hideaki Hara Breakdown of academic impact, for papers by Rosanna Di Paola Breakdown of academic impact, for papers by Rajiv R. Ratan Breakdown of academic impact, for papers by Domenico Praticò
Rankless by CCL
2026